MIT Technology Review's newsletters explore how AI tools could be misused to create bioweapons, citing a 2022 study where an AI drug-discovery model generated 40,000 potentially toxic molecules in under six hours. The coverage also notes that advances in gene editing and synthetic biology have made biotech more accessible, even as safeguards remain imperfect.
Iceland-based Treble, founded in 2020 by acoustic engineers Finnur Pind and Jesper Pedersen, has closed an $18 million extension to its Series A round led by Paladin Capital Group, with backing from KOMPAS VC, Frumtak Ventures, EIC, and Omega ehf. The funding brings Treble's total raised to over $40 million, following a $12 million round in 2024, and the company already counts Amazon and Logitech among its customers.
Datamimic has released a Community Edition of its data engine as an open-source, MIT-licensed, Python-native tool that generates deterministic synthetic datasets and pseudonymizes PII in staging or QA exports. The CE version runs standalone across databases and file formats like PostgreSQL, MongoDB, CSV and JSON, while a paid Enterprise Platform adds governed workflows, PII scanning, access controls, audit logging and scheduling for regulated industries.
A compiled body of scientific literature examines how microbial and engineered enzymes degrade synthetic polymers, with much of the progress concentrated on PET plastics through hydrolase and cutinase-based approaches. The references trace advances from early enzymatic surface modification studies to more recent engineered PET depolymerases capable of breaking down and recycling plastic bottles at scale.
TechCrunch Disrupt 2026, running October 13-15 in San Francisco, will host a fireside chat titled 'Can We Engineer Nature's Comeback?' featuring Ben Lamm, co-founder and CEO of Colossal Biosciences. The session will examine how AI and synthetic biology are being used to attempt reviving extinct species and what that means for conservation efforts.
A new evaluation of AI research agents, described by researcher Sayash Kapoor, found the systems performed strong engineering tasks but produced papers far below top AI conference standards. The agents ran flawed experiments, struggled to explain their findings clearly, abandoned promising hypotheses too early, and failed to meaningfully use feedback, time, or compute resources.
The European Space Agency is pressing ahead with its Envision mission to Venus after NASA signaled it likely can't deliver the US-built synthetic aperture radar it had promised under a 2024 partnership agreement. That radar was meant to be the spacecraft's main tool for mapping the planet's volcanic surface through its thick sulfuric-acid clouds at ten times the resolution of NASA's 1990s Magellan mission. ESA's project scientist says development will continue at full pace regardless.
Academic group b.next set out in 2023 to build a simple open-source synthetic cell sensor using fully specified components, aiming to make an accessible version of the PURE protein synthesis system. That effort snowballed into building actual manufacturing infrastructure, and the team now runs a plant producing 'Cytosol,' a core material for constructing synthetic cells based on open Nucleus specifications, having recently shipped its 100th kit.
b.next, originally an academic effort focused on synthetic cell interoperability through its Nucleus platform, took on a 2023 contract to build an open, fully specified synthetic cell sensor. That project, intended to take months, evolved into years of work solving supply chain gaps for PURE system components, ultimately leading the team to build a manufacturing plant producing 'Cytosol,' a core substrate for synthetic cells, and recently shipping its 100th kit.
Scientists engineered synthetic protein assemblies from the bottom up that can package and transport RNA molecules into human cells, using standard molecular cloning and transfection techniques in HEK293T cell lines. They validated the approach with a split-luciferase reporter system to confirm successful RNA delivery and functional expression inside cells.
Generative AI tools from companies like OpenAI, Google and Meta have made it far easier to produce convincing fake audio, video and images of public figures, fueling a rise in political deepfakes. Doppel's Bobby Ford describes the trend as driven by three factors: greater volume, faster velocity and more vectors such as video, audio and email being exploited by bad actors. The piece cites the 2024 New Hampshire robocall incident, where an AI-generated fake of Joe Biden's voice urged voters to stay home, as an early warning sign for what could happen in the 2026 midterms.
Researchers have devised a method to operate two separate genetic codes at once without needing to re-engineer an organism's entire genome to accommodate the change. The approach was tested outside living cells, so it avoids the laborious process of altering every gene, as previous efforts required when adding new amino acids to bacterial proteins.